Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”

Wee Loon Ong; Liying Zhang; Andrew Loblaw

doi:10.1016/j.radonc.2023.109918

Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”

Wee Loon Ong, Liying Zhang, Andrew Loblaw

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Article number	109918
Number of pages	1
Journal	Radiotherapy and Oncology
Volume	189
DOIs	https://doi.org/10.1016/j.radonc.2023.109918
Publication status	Published - Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.radonc.2023.109918

Cite this

@article{1c100f8786fa433496791480caf983b5,

title = "Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”",

author = "Ong, {Wee Loon} and Liying Zhang and Andrew Loblaw",

year = "2023",

month = dec,

doi = "10.1016/j.radonc.2023.109918",

language = "English",

volume = "189",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier",

}

TY - JOUR

T1 - Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”

AU - Ong, Wee Loon

AU - Zhang, Liying

AU - Loblaw, Andrew

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85175820416&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2023.109918

DO - 10.1016/j.radonc.2023.109918

M3 - Letter

C2 - 37776903

AN - SCOPUS:85175820416

SN - 0167-8140

VL - 189

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

M1 - 109918

ER -

Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”

UN SDGs

Access to Document

Other files and links

Research output

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer

Cite this